GE Healthcare, Medtronic Partnership Accelerates Global Access to Personalized Care by Delivering Advanced Patient Monitoring Solutions on the CARESCAPE Platform
businesswire.com
news
2022-06-01 00:00:00

June 01, 2022 08:00 AM Eastern Daylight Time CHICAGO & DUBLIN--(BUSINESS WIRE)--Clinicians now have added ability to personalize care with the integration of two continuous monitoring solutions from Medtronic plc (NYSE: MDT) – Microstream™ capnography (CO2) and INVOS™ regional oximetry (rSO2) technology for perioperative and ICU care on the GE Healthcare (NYSE: GE) CARESCAPE precision monitoring platform. FDA clearance and CE Mark approval of the integration of these latest technologies on the CARESCAPE platform completes the full suite of Medtronic patient monitoring technologies available on the system.
